Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses

K. W. Peng, R. Myers, A. Greenslade, E. Mader, S. Greiner, M. J. Federspiel, A. Dispenzieri, S. J. Russell

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Fingerprint

Dive into the research topics of 'Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses'. Together they form a unique fingerprint.

Medicine & Life Sciences